Romidepsin is an effective and well-tolerated therapy in CD3 [electronic resource]
Producer: 20201015Description: 2885-2887.e1 p. digitalISSN:- 2213-2201
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.